In MCI, both plasma p-tau 181 and p-tau217 have shown to be promising in predicting accurately future cognitive decline and ADD conversion in the subsequent 2 to 6 years, again with an accuracy similar to that of the corresponding p-tau isoform measured in CSF [10,29]. This evidence concerns the gene MAPT and Mental deterioration.